{"id":"https://openalex.org/W4200225484","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.434","title":"P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection","display_name":"P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection","publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200225484","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.434"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2021.10.434","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.434","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2021.10.434","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066241810","display_name":"Itay Perlstein","orcid":"https://orcid.org/0000-0001-8700-3957","observed_orcids":["https://orcid.org/0000-0001-8700-3957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Perlstein","raw_affiliation_strings":["Magic Wand Research- LLC, Consultant, Philadelphia PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Magic Wand Research- LLC, Consultant, Philadelphia PA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042927796","display_name":"A. Merenlender Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"A. Merenlender Wagner","raw_affiliation_strings":["Teva Pharmaceutical Industries- Ltd, Research and Development, Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries- Ltd, Research and Development, Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077275899","display_name":"Michael J. Lamson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Lamson","raw_affiliation_strings":["Nuventra Pharma, Consultant, Durham NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuventra Pharma, Consultant, Durham NC, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076108650","display_name":"Ofer Spiegelstein","orcid":"https://orcid.org/0009-0006-1758-1202","observed_orcids":["https://orcid.org/0009-0006-1758-1202"]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"O. Spiegelstein","raw_affiliation_strings":["Teva Pharmaceutical Industries- Ltd, Research and Development, Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries- Ltd, Research and Development, Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060639413","display_name":"Pippa S. Loupe","orcid":"https://orcid.org/0000-0002-2161-5050","observed_orcids":["https://orcid.org/0000-0002-2161-5050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Loupe","raw_affiliation_strings":["Teva Pharmaceutical Industries- Ltd, Research and Development, New Orleans LA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries- Ltd, Research and Development, New Orleans LA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087777889","display_name":"Roberto Gom\u00e9ni","orcid":"https://orcid.org/0000-0003-3916-9578","observed_orcids":["https://orcid.org/0000-0003-3916-9578"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Gomeni","raw_affiliation_strings":["Pharmacometrica, Consultant, Chapel Hill NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacometrica, Consultant, Chapel Hill NC, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049144787","display_name":"Anna Elgart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109720","display_name":"Teva Pharmaceuticals (Israel)","ror":"https://ror.org/01wfv3m53","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210109720"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"A. Elgart","raw_affiliation_strings":["Teva Pharmaceutical Industries- Ltd, Research and Development, Netanya, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries- Ltd, Research and Development, Netanya, Israel","institution_ids":["https://openalex.org/I4210109720"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.2066,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.57384333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"53","issue":null,"first_page":"S338","last_page":"S338"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.6723999977111816,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.23899999260902405,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.026900000870227814,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9419999718666077},{"id":"https://openalex.org/keywords/long-acting-injectable-antipsychotics","display_name":"long-acting injectable antipsychotics","score":0.890999972820282},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.9459999799728394},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.8370000123977661},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.9110000133514404},{"id":"https://openalex.org/keywords/nicotine-dependence","display_name":"nicotine dependence","score":0.8830000162124634},{"id":"https://openalex.org/keywords/dentists","display_name":"dentists","score":0.9559999704360962},{"id":"https://openalex.org/keywords/smoking-prevalence","display_name":"smoking prevalence","score":0.6629999876022339},{"id":"https://openalex.org/keywords/anti-smoking-interventions","display_name":"anti-smoking interventions","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7737414836883545},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.7657439112663269},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.7170459032058716},{"id":"https://openalex.org/C2778647338","wikidata":"https://www.wikidata.org/wiki/Q18553444","display_name":"Nicotine dependence","level":3,"score":0.5829861164093018},{"id":"https://openalex.org/C2909683868","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine Addiction","level":3,"score":0.5555970072746277},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5244850516319275},{"id":"https://openalex.org/C2780665704","wikidata":"https://www.wikidata.org/wiki/Q959298","display_name":"Intervention (counseling)","level":2,"score":0.4902051091194153},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.44323113560676575},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.42113399505615234},{"id":"https://openalex.org/C199343813","wikidata":"https://www.wikidata.org/wiki/Q12128","display_name":"Dentistry","level":1,"score":0.3492010831832886},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33781129121780396},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.32042059302330017},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2282530665397644},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.1321948766708374},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.euroneuro.2021.10.434","doi":"https://doi.org/10.1016/j.euroneuro.2021.10.434","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2021.10.434","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W1972852190"],"related_works":["https://openalex.org/W4200202668","https://openalex.org/W4200306472","https://openalex.org/W4200545220","https://openalex.org/W4200251068","https://openalex.org/W2315622133","https://openalex.org/W2590065710","https://openalex.org/W2529263510","https://openalex.org/W4248439324","https://openalex.org/W2460064789","https://openalex.org/W3187873609"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-12-31T00:00:00"}